Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Intervention Indication Therapeutic Area Year Actions
Pralsetinib for treating thyroid cancer Pralsetinib (BLU-667; Gavreto) Thyroid cancer Oncology 2021 View  |  Download
Selpercatinib for advanced thyroid cancer with RET alterations Selpercatinib (LOXO-292; LY3527723) Medullary thyroid cancer (MTC) , Thyroid cancer Head and Neck Cancer , Oncology 2019 View  |  Download
Selpercatinib for previously untreated advanced RET-fusion positive thyroid cancer Selpercatinib (LOXO-292; LY3527723) Thyroid cancer Oncology 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications